These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30160355)

  • 1. Outcome of Wilms tumor patients with bone metastasis enrolled on National Wilms Tumor Studies 1-5: A report from the Children's Oncology Group.
    Iaboni DSM; Chi YY; Kim Y; Dome JS; Fernandez CV
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27430. PubMed ID: 30160355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of synchronous bilateral Wilms tumor: a report from the National Wilms Tumor Study Group.
    Hamilton TE; Ritchey ML; Haase GM; Argani P; Peterson SM; Anderson JR; Green DM; Shamberger RC
    Ann Surg; 2011 May; 253(5):1004-10. PubMed ID: 21394016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
    Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
    J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group.
    Kalapurakal JA; Nan B; Norkool P; Coppes M; Perlman E; Beckwith B; Ritchey M; Breslow N; Grundy P; D'angio GJ; Green DM; Thomas PR
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1379-84. PubMed ID: 15590168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
    Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
    J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.
    Daw NC; Chi YY; Kim Y; Mullen EA; Kalapurakal JA; Tian J; Khanna G; Geller JI; Perlman EJ; Ehrlich PF; Warwick AB; Grundy PE; Fernandez CV; Dome JS;
    Eur J Cancer; 2019 Sep; 118():58-66. PubMed ID: 31325873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of bilateral Wilms tumor over three decades: The perspective of a single center.
    User IR; Ekinci S; Kale G; Akyüz C; Büyükpamukçu M; Karnak I; Çiftçi AÖ; Tanyel FC; Şenocak ME
    J Pediatr Urol; 2015 Jun; 11(3):118.e1-6. PubMed ID: 25842994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is radiotherapy required in first-line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP-RTSG, AIEOP, JWiTS, and UKCCSG.
    Fajardo RD; van den Heuvel-Eibrink MM; van Tinteren H; Spreafico F; Acha T; Bergeron C; de Camargo B; Oldenburger F; Rübe C; Oue T; Vokuhl C; de Krijger RR; Vujanic G; Sebire N; Coulomb-L'Hermine A; Collini P; Gandola L; Pritchard-Jones K; Graf N; Janssens GO; van Grotel M
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28039. PubMed ID: 31625685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic metastasis at diagnosis in patients with Wilms tumor is not an independent adverse prognostic factor for stage IV Wilms tumor: a report from the Children's Oncology Group/National Wilms Tumor Study Group.
    Ehrlich PF; Ferrer FA; Ritchey ML; Anderson JR; Green DM; Grundy PE; Dome JS; Kalapurakal JA; Perlman EJ; Shamberger RC
    Ann Surg; 2009 Oct; 250(4):642-8. PubMed ID: 19730241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532.
    Fernandez CV; Perlman EJ; Mullen EA; Chi YY; Hamilton TE; Gow KW; Ferrer FA; Barnhart DC; Ehrlich PF; Khanna G; Kalapurakal JA; Bocking T; Huff V; Tian J; Geller JI; Grundy PE; Anderson JR; Dome JS; Shamberger RC
    Ann Surg; 2017 Apr; 265(4):835-840. PubMed ID: 27811504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital.
    Dome JS; Liu T; Krasin M; Lott L; Shearer P; Daw NC; Billups CA; Wilimas JA
    J Pediatr Hematol Oncol; 2002; 24(3):192-8. PubMed ID: 11990305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver metastasis at diagnosis in children with nephroblastoma enrolled in SIOP2001 protocol: A French multicentric study.
    Liné A; Sudour-Bonnange H; Languillat-Fouquet V; Brisse H; Irtan S; Verschuur A; Sarnacki S; Thébaud E; Coulomb-L'Hermine A; Notz-Carrère A; Michon J; Tabone MD; Boulanger C; Pellier I; Freycon C; Audry G; Dijoud F; Morelle M; Bergeron C; Pasqualini C
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28201. PubMed ID: 32207555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and outcome of pediatric metastatic Wilms' tumor at the National Cancer Institute, Egypt.
    Elayadi M; Magdy S; Khalil E; Zekri W
    J Egypt Natl Canc Inst; 2020 Apr; 32(1):19. PubMed ID: 32372204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534.
    Romao RLP; Aldrink JH; Renfro LA; Mullen EA; Murphy AJ; Brzezinski J; Malek MM; Benedetti DJ; Cost NG; Smith E; Dome JS; Davidoff AM; Treece A; Parsons LN; Fernandez CV; Tornwall B; Shamberger RC; Paulino A; Kalapurakal JA; Geller JI; Ehrlich PF
    Pediatr Blood Cancer; 2024 Jul; 71(7):e30981. PubMed ID: 38637871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognosis of prechemotherapy blastemal predominant histology subtype in Wilms tumor: A retrospective study in China.
    Huang J; Zhang Y; Zhen Z; Lu S; Zhu J; Wang J; Sun F; Liu Z; Gao Y; Li H; Zhang Y; Sun X
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28567. PubMed ID: 32813315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of children with favorable histology wilms tumor and peritoneal implants treated in National Wilms Tumor Studies-4 and -5.
    Kalapurakal JA; Green DM; Haase G; Anderson JR; Dome JS; Grundy PE
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):554-8. PubMed ID: 20457352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome analysis of stage I epithelial-predominant favorable-histology Wilms tumors: A report from Children's Oncology Group study AREN03B2.
    Parsons LN; Mullen EA; Geller JI; Chi YY; Khanna G; Glick RD; Aldrink JH; Vallance KL; Kim Y; Fernandez CV; Dome JS; Perlman EJ
    Cancer; 2020 Jun; 126(12):2866-2871. PubMed ID: 32267967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and outcome of inoperable Wilms tumor. A report of National Wilms Tumor Study-3.
    Ritchey ML; Pringle KC; Breslow NE; Takashima J; Moksness J; Zuppan CW; Beckwith JB; Thomas PR; Kelalis PP
    Ann Surg; 1994 Nov; 220(5):683-90. PubMed ID: 7979618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
    Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
    J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaplastic Wilms' tumor: clinical and pathologic studies.
    Bonadio JF; Storer B; Norkool P; Farewell VT; Beckwith JB; D'Angio GJ
    J Clin Oncol; 1985 Apr; 3(4):513-20. PubMed ID: 2984344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.